Bilberry: Benefits, Dosage, and What the Research Says

Bilberry (Vaccinium myrtillus L.), commonly called the European blueberry or whortleberry, is a small, wild berry native to Northern and Central Europe, parts of Asia, and high-altitude regions of North America. It grows wild across subarctic forests and mountain meadows and has been harvested for centuries as both food and medicine.

What makes bilberry distinctive in the Vaccinium genus is its deep-blue flesh. Unlike cultivated blueberries (V. corymbosum) whose anthocyanins are concentrated mainly in the skin, bilberry's pigments saturate the entire fruit. This reflects an extraordinarily high anthocyanin content: 300-700 mg per 100 g of fresh fruit, among the richest of any berry. Fifteen distinct anthocyanin compounds have been identified in bilberry, built on five aglycone backbones — delphinidin, cyanidin, petunidin, peonidin, and malvidin — each paired with galactose, glucose, or arabinose sugar units.⁷ This diverse anthocyanin profile is believed to underpin bilberry's broad range of biological activities.

Beyond anthocyanins, bilberry also contains quercetin, catechins, tannins, phenolic acids, and small amounts of vitamins C and E. In supplement form, the dried ripe berry is typically extracted and standardized to deliver a consistent anthocyanin dose — most commercial products specify 25% or 36% anthocyanins by weight.

Bilberry vs. common blueberry

The two berries are close botanical relatives but differ meaningfully for supplement purposes. Wild bilberry contains roughly 3-5 times more anthocyanins per gram than cultivated blueberries, and the anthocyanin chemistry differs slightly. Most clinical research on bilberry for eye health and cardiometabolic support has used European bilberry extract specifically, not common blueberry, so the two should not be assumed interchangeable when evaluating study outcomes.

Bilberry anthocyanins interact with human biology through several overlapping mechanisms rather than a single pathway:

• Direct antioxidant activity: Anthocyanins are potent electron donors and iron chelators that scavenge reactive oxygen species (ROS) in tissues, including the metabolically active cells of the retina, blood vessel walls, and skin.
• NF-κB pathway inhibition: Bilberry suppresses the nuclear factor kappa-B (NF-κB) signaling cascade — a master switch of inflammatory gene expression — reducing downstream production of TNF-α, interleukin-6, and IL-1β in both cell and human studies.⁷
• Enzyme inhibition in the gut: Anthocyanins inhibit α-glucosidase and alpha-amylase, two digestive enzymes that break down dietary starch and sugars. By slowing this breakdown, bilberry may reduce the rate of glucose entering the bloodstream after a meal.⁷
• Microvascular stabilization: Anthocyanins help reinforce collagen cross-linking in capillary walls and support healthy perfusion in the fine blood vessels that nourish the retina and optic nerve.
• JAK-STAT signaling modulation: In preclinical retinal models, bilberry extract prevented STAT3 activation and the subsequent IL-6-driven decrease in photoreceptor protein rhodopsin.⁹ (Tier C — animal finding.)

Bioavailability of anthocyanins is relatively low: plasma concentrations typically peak at 5-50 nmol/L roughly 1-2 hours after an oral dose and are largely cleared by the kidneys within 6 hours. Gut microbiota further transform anthocyanins into phenolic acid metabolites — including 4-hydroxyphenylpropionic acid — that may contribute additional effects, particularly on vascular tone and blood pressure.⁵ This may help explain why individual responses to bilberry supplementation vary based on a person's gut microbiome composition.

Eye health is bilberry's most-studied supplement application and the area where the clinical evidence is strongest, though still based on relatively small trials. Research covers three distinct aspects: visual accommodation during screen work, dry eye symptoms, and intraocular pressure support.

What the research shows: visual accommodation and screen-related eye strain

A 12-week, randomized, double-blind, placebo-controlled parallel-group trial enrolled 109 healthy adults aged 20-60 who were randomized to receive either 240 mg/day of standardized bilberry extract (SBE) or placebo. Eye accommodation was measured objectively before and after standardized visual display terminal (VDT) tasks using high-frequency components of ciliary muscle activity (HFC-1). Post-VDT load values were significantly better in the bilberry group at both week 8 (p = 0.014) and week 12 (p = 0.017) compared to placebo. The authors concluded that 12 weeks of oral SBE supplementation relieves tonic accommodation of the ciliary muscle caused by VDT tasks.² No serious adverse events were recorded in either group. This finding is particularly relevant as extended screen use has become nearly ubiquitous in modern life.

What the research shows: dry eye symptoms

A randomized, double-blind, placebo-controlled trial in 22 healthy subjects with dry eye symptoms found that 4 weeks of Mirtoselect® (a standardized bilberry extract) significantly improved Schirmer's test values — a direct measure of tear secretion — versus placebo (p = 0.019). The bilberry group also showed significant improvement in biological antioxidant potential (BAP, p = 0.003), suggesting an antioxidant mechanism at the ocular surface.³ This was a small, single-center trial; larger studies are needed to confirm the finding.

What the research shows: intraocular pressure

A 4-week pilot study in 18 patients with primary open-angle glaucoma already receiving prescription medication found that daily supplementation with a tablet containing 90 mg bilberry fruit extract and 40 mg French maritime pine bark extract reduced Goldmann intraocular pressure (IOP) from 17.2 mmHg at baseline to 15.7 mmHg — an 8.7% decrease (p = 0.0046).⁸ Importantly, this was a combination product in a small population already on IOP-lowering drugs; the isolated contribution of bilberry cannot be determined from this study. Anyone with glaucoma should work with their ophthalmologist rather than substitute or adjust prescribed treatment.

The night vision claim: what the evidence actually shows

The longstanding reputation of bilberry for improving night vision — sometimes attributed to Royal Air Force pilots in World War II consuming bilberry jam — is not supported by rigorous clinical evidence. A systematic review identified 30 trials with night-vision outcome measures; of the 12 that were placebo-controlled, the four most recent and methodologically rigorous randomized controlled trials all showed no benefit in subjects with normal or above-average vision. The reviewers concluded that the hypothesis that bilberry anthocyanosides improve night vision in healthy individuals is not supported by evidence from rigorous clinical studies.¹ Whether bilberry could benefit individuals with pathological impairment of night vision has not been adequately studied.

A meaningful body of research has examined bilberry and related berry extracts for cardiometabolic outcomes. The results are most consistent in higher-risk populations — people with type 2 diabetes, pre-diabetes, or metabolic syndrome — and more modest in healthy adults.

What the research shows: blood sugar management

A double-blind, crossover RCT in adults with type 2 diabetes managed by diet and lifestyle found that a single supplement of standardized bilberry extract (36% anthocyanins by wet weight) modified the postprandial glycaemic response compared to placebo.⁶ A broader systematic review of 24 intervention trials using bilberry and blackcurrant extracts found that these interventions reduced HbA1c by approximately 4.7% on average and decreased fasting blood glucose by roughly 3%, with effects most pronounced in older subjects with type 2 diabetes in longer-term studies.⁴ The plausible mechanism is inhibition of gut α-glucosidase activity, slowing carbohydrate digestion. Effect sizes in metabolically healthy adults are smaller and less consistent.

What the research shows: blood pressure

The PRECISE study — a double-blind, placebo-controlled crossover RCT — tested a combined grape seed and bilberry extract in 14 adults at risk for type 2 diabetes. Ambulatory systolic blood pressure fell by 4.7 mmHg (p < 0.001) and diastolic by 2.3 mmHg (p = 0.0009) versus placebo, a reduction the authors described as comparable with antihypertensive drug treatment for this population.⁵ Notably, participants who responded best had higher baseline levels of fecal phenolic metabolites and specific gut bacteria (Fusicatenibacter-related species), suggesting that microbiome composition predicts individual response. The small sample and use of a combination product (grape seed plus bilberry) are important limitations.

What the research shows: cholesterol

The same systematic review found that bilberry and blackcurrant extracts reduced LDL cholesterol by 6-9.8% and total cholesterol by 3-4%, and raised HDL cholesterol by 7.8%, most reliably in subjects with hypercholesterolemia, type 2 diabetes, or metabolic syndrome.⁴ Study quality varied — roughly half the trials lacked adequate randomization documentation and dropout rates ranged from 1% to 38% — so these figures should be interpreted conservatively. Bilberry should not be treated as a first-line cholesterol intervention, but may be a reasonable adjunct to discuss with a healthcare provider in the context of a broader lifestyle plan.

Bilberry's anthocyanins function as systemic antioxidants. A 2022 review of clinical evidence concluded that bilberry supplementation — across formats including whole frozen fruit, juice, and standardized extracts — reduced circulating inflammatory markers (TNF-α, IL-6) in the majority of human metabolic disorder studies reviewed.⁷

What the research shows

A 2024 randomized, double-blind, placebo-controlled trial enrolled 65 adults with visible crow's feet wrinkles and uneven skin tone. After 84 days of fermented bilberry extract supplementation, the bilberry group showed statistically significant improvements over placebo in skin antioxidant capacity (+20.8%), firmness (+13.3%), elasticity (+12.4%), and wrinkle depth (-10.6%).¹⁰ Compliance was 98-99% and the product was well tolerated. While this is a single trial and focused on cosmetic outcomes, it provides human evidence that bilberry anthocyanins measurably raise antioxidant status in peripheral tissues over a sustained period.

At the cellular level, preclinical models show that bilberry anthocyanins activate the heme oxygenase-1 (HO-1) antioxidant enzyme pathway and inhibit NF-κB in retinal pigment epithelium cells — actions that may help explain the ocular surface protection seen in human trials.⁹ These are Tier C (animal/cell) findings; direct evidence for bilberry's cellular antioxidant action in the human retina has not been established in clinical studies.